Skeletal Dysplasias Flashcards
What are clinical features of achondroplasia?
Disproportionate short stature
(usually under 4 feet 6 inches)
* Macrocephaly with frontal bossing
(large head, prominent forehead)
* Midface retrusion and depressed
nasal bridge (flat face / nose)
* Rhizomelic (proximal) shortening of
the arms with redundant skin folds
on limbs
* Limited elbow extension
* Brachydactyly
- “Trident” hands
- Genu varum (bowlegs)
- Thoracolumbar kyphosis (excessive
forward curvature of the spine in the
upper back) and exaggerated lumbar
lordosis - Leads to prominent appearance of
abdomen and buttocks - Developmental motor milestones can
be delayed - Intelligence and life span are typically
near normal - Related complications can may affect
these
What gene is associated with achondroplasia?
FGFR3 mutation
* Gene that makes a protein that is
involved in cell division, cell
maturation, formation of new blood
vessels, wound healing, and bone
growth, development, and
maintenance.
What is the MOI for achondroplasia?
AD; 80% de novo, 100% penetrant
Increased risk with APA
What is homozygous achondroplasia? (SADDAN)
Biallelic pathogenic variants at nucleotide 1138 of FGFR3
* Severe disorder
* Early death results from respiratory insufficiency because of
the small thoracic cage and neurologic deficit from
What medication is often used to treat achondroplasia?
VOXZOGO® (vosoritide) FDA-approved
treatment used to increase linear growth in
pediatric patients with achondroplasia who
are 5 years of age and older with open
epiphyses. Costs about $320,000 per year
What are the clinical features of hypochondroplasia?
Clinical Features
* Short stature (adult height 128-165
cm; 2-3 SD below the mean in
children)
* Stocky build
* Shortening of the proximal or
middle segments of the extremities
(rhizomelia or mesomelia)
* Limited elbow extension
* Broad, short hands and feet with
brachydactyly
* Generalized, mild joint laxity
* Macrocephaly with relatively
normal facies
Less common clinical features:
* Scoliosis
* Genu varum (bowlegs; usually
mild)
* Lumbar lordosis with protruding
abdomen
* Mild-to-moderate intellectual
disability
* Learning disabilities
* Adult-onset osteoarthritis
* Acanthosis nigricans
* Temporal lobe epilepsy
What gene is associated with hypochondroplasia?
FGFR3
“Majority” of cases are de novo
* Variable penetrance (due to height range
overlap with unaffected populations)
Hypochondroplasia has skeletal and medical issues that are more mild / less frequent than
achondroplasia
* Hypochondroplasia features may present later
in life and not be identified at birth
* ID and epilepsy may be more prevalent in
hypochondroplasia
What are features of Cleidocranial dysplasia (CCD)
spectrum disorder?
Ranges from
* Classic presentation (triad of delayed closure of the cranial sutures, hypoplastic or aplastic clavicles, and dental
abnormalities)
* Mild CCD
* Isolated dental anomalies without other skeletal features
Clinical findings
* Abnormally large, wide-open fontanelles at birth
* Broad, flat forehead; cranium is brachycephalic
* Frontal and parietal bossing and mid-face retrusion
* Narrow, sloping shoulders that can be opposed at the midline due to clavicular hypoplasia or
aplasia
* Delayed eruption of secondary dentition, failure to shed the primary teeth, variable numbers
of supernumerary teeth along with dental crowding, and malocclusion
* Hand abnormalities including brachydactyly, tapering fingers, and short, broad thumbs
* Short stature (typically moderate, boys a little shorter than girls)
* Increased risk of recurrent sinus infections, recurrent ear infections leading to conductive
hearing loss, and upper-airway obstruction
* Conductive hearing loss occurs in 39% of affected individuals.
* Normal intellect in individuals with classic CCD spectrum disorder
Diagnosis of CCD
Characteristic clinical and
radiographic findings and/or
mutation in RUNX2 (CBFA1).
- RUNX2 provides instructions for
making a protein (transcription factor)
that is involved in the development
and maintenance of the teeth, bones,
and cartilage. - No formal clinical diagnostic criteria for
CCD spectrum disorder have been
established.
AD
* High proportion of cases are de novo
* High penetrance and extreme
variability.
What is the prevalence of Diastrophic dysplasia?
Prevalence unknown, suspected to be 1 in 100,000
1/33,000 in Finland (founder mutation - approximately 90% of the individuals with DTD in Finland
carry the founder mutation c.-26+2T>C, either in homozygosity or compounded with another
SLC26A2 mutation
What are the clinical features of Diastrophic dysplasia?
Clinical Features
* Limb shortening
* Normal-sized head
* Slight trunk shortening
* Hitchhiker thumbs
* Symphalangism (fusion of the joints of the fingers or toes) with missing interphalangeal creases
* Small chest
* Protuberant abdomen
* Normal intelligence
* Contractures of large joints
* Dislocation of the radius
* Cleft palate (in ~1/3 of individuals)
* Cystic ear swelling in the neonatal period (in ~2/3 of infants)
* Ulnar deviation of the fingers, gap between the first and second toes, clubfoot, and flat hemangiomas of the
forehead
What is the distinguishing clinical feature of Diastrophic dysplasia?
Hitchhiker thumbs
What gene is associated with Diastrophic dysplasia?
SLC26A2
* Protein transports sulfate ions used by
cartilage to build proteoglycans
* Fibroblast and/or chondrocyte testing
may be used if no SLC26A2
pathogenic variants found (rare)
* AR
What is Hereditary Multiple Osteochondromas (HMO) Syndrome? What is the prevalence?
Prevalence: 1 in 100 in a small population in Guam; 1 in 50,000 in Washington State*; 1 in
100,000 in European populations
What is the gene associated with and molecular mechanism of HMO Syndrome?
EXT1 or EXT2
* EXT1 and EXT2 help produce exostosin-1 and 2
* These two proteins bind together in the Golgi
apparatus, which modifies newly produced
enzymes and other proteins.
* In the Golgi apparatus, the exostosin-1 and
exostosin-2 complex modifies a protein called
heparan sulfate so it can be used by the cell.
* Heparan sulfate is involved in many bodily
processes, it is unclear how the lack of this protein
contributes to the development of
osteochondromas.
What is the MOI for HMO Syndrome?
AD
* 10% of cases are de novo
* 96% penetrant in females
* 100% penetrant in males
What other risks come with HMO Syndrome?
The risk for malignant degeneration to osteochondrosarcoma increases with age
* Lifetime risk for malignant degeneration is ~2%-5%
What is Spondyloepiphyseal Dysplasia congenita (SEDC)? What is the prevalence?
More than 175 cases reported
in the scientific literature
* Present neonatally with severe
disproportionate short stature,
short extremities (<5th
percentile), characteristic
facial features (hypertelorism,
flat profile, PRS), myopia, and
hearing loss, barrel chest
* Radiographs display
delayed/poor ossification of
the vertebrae and the pubic
bones, and the long bones are
short with hypoplastic
epiphyses
Type II Collagen Disorder
- Increased risk for cervical
instability and spinal cord
compression (as seen in Kniest
dysplasia), and individuals with
SEDC are also at greater risk for
tracheolaryngomalacia (collapse of
trachea and laryngeal structures)
* SEDC cannot be distinguished from
Spondyloepimetaphyseal dysplasia
(SEMD), Strudwick type until later
in the first year of life, since
metaphyseal dysplasia in the latter
is not present at birth
Occurs in less than 1 in 100,000 births
Diagnosis of SEDC
Based on clinical and radiologic
findings and the identification of a
pathogenic variant in COL2A1, and
involves medical history, physical
examination, x-rays, family history, and
genetic testing.
* No formal clinical diagnostic criteria exist;
specific diagnosis should be confirmed by
genetic testing
What gene is associated with SEDC? What is the molecular mechanism?
- AD;AR reported in two families
- Highly penetrant
- COL2A1 (makes pro-α1(I) chains, a
component of type II collagen
What is OI?
There are at least 19 recognized
forms of osteogenesis imperfecta,
however OI is phenotypically divided
into five groups, from OI types 1 to
5*.
* Two classification types: Sillence and
genetically defined types.
* In more than 90% of cases, OI occurs
due to mutations in the COL1A1 or
COL1A2 genes (mostly autosomal
dominant, can be de novo)
* OI can involve other genes and/or
inheritance patterns – See Table 5 in
GeneReviews
https://www.ncbi.nlm.nih.gov/books/NBK12
95/
What genes are associated with OI?
- Covered here: OI forms that are
AD (or de novo) and caused by
mutations in COL1A1, COL1A2 - Type I collagen is composed of two
pro-α1(I) chains and one pro-α2(I)
chain (which is produced from
the COL1A2 gene). - Type I collagen is the most
abundant form of collagen in the
human body.